Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brisdelle Phase 3 for Menopausal VMS (12-week)
NCT01361308Phase 3Completed
- Sponsor
- Noven Therapeutics, LLC
- Start
- May 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paroxetine in vasomotor symptoms of menopause (VMS), sponsored by Noven Therapeutics, LLC. Started May 2011; status: completed.
02
Drugs
paroxetine
03
Conditions
vasomotor symptoms of menopause (VMS)
Beyond the preview
Go deeper on NCT01361308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01361308.